Search

everythinglearnresearchcommunity

for

Search:↓

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

UV light helped human hair transplants survive in mice without broad immunosuppression.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Intermediate filaments are crucial for cell differentiation and stem cell function.

When skin blisters, healing the wound is more important than growing hair, and certain stem cells mainly fix the blisters without helping hair growth.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Cancer development is like natural selection, involving mutated cells and environmental factors.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Leflunomide is more likely to help treat alopecia areata than cause it.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.